Supplemental Figures for "Cancer and Healthcare Reform: Making the Pieces Fit"

Publication
Article
OncologyONCOLOGY Vol 25 No 9
Volume 25
Issue 9

Note:These supplemental figures provide concrete illustrations of a number of the authors’ points.

Articles in this issue
Management of DCIS-A Work in Progress
Tailored Strategies for DCIS Management
Neuroendocrine Tumors: a Heterogeneous Set of Neoplasms
Surgical Management of Neuroendocrine Tumors of the Gastrointestinal Tract
Can We Know What to Do When DCIS Is Diagnosed?
A Rare Case of Metastatic Renal Epithelioid Angiomyolipoma
The Changing Field of Locoregional Treatment for Breast Cancer
Surgical Management of Neuroendocrine Tumors: Treatment of Localized and Metastatic Disease
Cancer and Healthcare Reform: Making the Pieces Fit
Cancer and Healthcare Reform: Making the Pieces Fit
An Approach to the Management of Rare Tumors
Supplemental Figures for "Cancer and Healthcare Reform: Making the Pieces Fit"
Malignant Angiomyolipoma: a Rare Entity With Unusual Biology
Locoregional Treatment of Breast Cancer: Where to Next?
Progress but Not Perfection: Ongoing Efforts to Optimize Locoregional Treatments for Breast Cancer
Mangosteen (Garcinia mangostana)
Mangosteen (Garcinia mangostana)
Recent Videos
Related Content
Addressing Gaps in Education for Non–Clear Cell RCC

Addressing Gaps in Education for Non–Clear Cell RCC

ONCOLOGY Staff
November 19th 2024
Article

A panel discussed on RCC and the differentiation in the identification and treatment of clear and non-clear cell RCC.

Stem Cell Transplant Approaches for Patients With Blood Cancers

Stem Cell Transplant Approaches for Patients With Blood Cancers

David T. Scadden, MD
March 13th 2019
Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.

BTK Inhibitor Treatment Options Across the Lymphoma Landscape

BTK Inhibitor Treatment Options Across the Lymphoma Landscape

ONCOLOGY Staff
November 17th 2024
Article

Clinicians focused on CLL, follicular lymphoma, and MCL gathered during a Frontline Forum to discuss the use of BTKi in each respective disease state.

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Geoffrey Y. Ku, MD
March 13th 2019
Podcast

Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.

Precision Medicine in NSCLC The Power of Molecular Testing

Precision Medicine in NSCLC The Power of Molecular Testing

Charu Aggarwal, MD, MPH;Christine Bestvina, MD;Hatim Husain, MD;Karen L. Reckamp, MD
November 13th 2024
Article

Personalized therapy for non–small cell lung cancer has evolved significantly with the advent of comprehensive molecular testing.

Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?

Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?

Natasha Bahri, MD, MS;Christiana Crook, MS;Daneng Li, MD
November 12th 2024
Article

Given that well-differentiated grade 3 NETs are relatively new, standard-of-care treatment options are undefined.